Fusion Antibodies Balance Sheet

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	0.25	0.36	1.2	0.2	2.05	2.69
Cash & Short-Term Investments	0.25	0.36	1.2	0.2	2.05	2.69
Cash Growth	-29.80%	-70.06%	514.87%	-90.48%	-23.72%	74.76%
Accounts Receivable	0.87	0.63	0.56	0.69	1.52	1.44
Other Receivables	-	-	0.05	0.26	0.13	0.1
Total Trade Receivables	0.87	0.63	0.6	0.95	1.65	1.54
Inventory	0.27	0.27	0.46	0.54	0.59	0.48
Total Current Assets	1.39	1.26	2.26	1.69	4.28	4.71
Net Property, Plant & Equipment	0.42	0.06	0.16	0.38	0.63	1.12
Other Intangible Assets	-	-	-	-	-	0
Total Assets	1.81	1.32	2.42	2.06	4.92	5.83
Accounts Payable	0.67	0.6	0.56	0.84	1.14	0.83
Current Portion of Long-Term Debt	0.11	0.02	0.02	0.04	0.07	0.16
Total Current Liabilities	0.77	0.62	0.58	0.88	1.21	1
Long-Term Debt	0.28	-	0.02	0.04	0	0.07
Other Long-Term Liabilities	0.03	0.03	0.02	0.02	0.02	0.02
Total Long-Term Liabilities	0.31	0.03	0.04	0.06	0.02	0.09
Total Liabilities	1.09	0.65	0.63	0.94	1.23	1.08
Common Stock	4.53	4.2	3.82	1.04	1.04	1.02
Additional Paid-in Capital	8.17	7.94	7.74	7.65	7.65	7.55
Retained Earnings	-11.98	-11.47	-9.77	-7.56	-5	-3.82
Shareholders' Equity	0.73	0.67	1.79	1.12	3.68	4.75
Total Liabilities & Equity	1.81	1.32	2.42	2.06	4.92	5.83
Total Debt	0.39	0.02	0.04	0.08	0.07	0.23
Net Cash (Debt)	-0.14	0.34	1.16	0.12	1.98	2.46
Net Cash Growth	-	-70.67%	863.33%	-93.94%	-19.38%	112.27%
Net Cash Per Share	-0.00	0.00	0.02	0.01	0.08	0.10
Book Value	0.73	0.67	1.79	1.12	3.68	4.75
Book Value Per Share	0.01	0.01	0.03	0.04	0.14	0.19
Tangible Book Value	0.73	0.67	1.79	1.12	3.68	4.75
Tangible Book Value Per Share	0.01	0.01	0.03	0.04	0.14	0.19